Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Alkem Laboratories Ltd.
₹5,385
Invest in ALKEM with up to 4.00x margin.
Trade with MTF₹5181.50
₹5386.50
₹4700.65
₹5933.50
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 2,491.27 | 2,542.03 | 2,372.17 | 2,044.94 | 2,286.83 |
| Operating Expense | 1,802.06 | 1,771.35 | 1,751.69 | 1,748.15 | 1,629 |
| Operating Profit | 689.21 | 770.68 | 620.48 | 296.79 | 657.83 |
| Depreciation | 60.91 | 58.59 | 58.89 | 91.64 | 67.61 |
| Interest | 15.51 | 12.75 | 12.79 | 16.91 | 21 |
| Tax | 84.01 | 77.05 | 57.41 | 73.95 | 62.17 |
| Net Profit | 622.14 | 786.73 | 656.16 | 276.94 | 723.12 |
Research Type
Equity , Long Term
Buy Range
₹5,402 - ₹0
Target Price
₹5,980
Stop Loss
-
Target Date
16 Feb 27
Potential Returns
10.70 %
₹5385.00
↗ Bullish Moving Average
8
↘ Bearish Moving Average
8
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 55.7 | 55.7 | 55.1 | 53 | 51.2 | 51.2 |
| FII | 9 | 10.1 | 9.4 | 9.1 | 9.5 | 10 |
| DII | 19.2 | 18.1 | 19.4 | 21.8 | 21.9 | 21.5 |
| Public | 16.1 | 16.2 | 16 | 16 | 17.4 | 17.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.29 L | 1.98 L | 65.15% |
| Week | 64.22 K | 1.23 L | 52.35% |
| 1 Month | 82.42 K | 1.41 L | 58.47% |
| 6 Month | 84.92 K | 1.36 L | 62.29% |
Benjamin Graham Value Screen
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Mid-range Performer (DVM)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 20 Feb, 2026 | 43 | INTERIM | 20 Feb, 2026 | Equity Share |
| 08 Aug, 2025 | 8 | FINAL | 08 Aug, 2025 | Equity Share |
| 14 Feb, 2025 | 37 | INTERIM | 14 Feb, 2025 | Equity Share |
| 09 Aug, 2024 | 5 | FINAL | 10 Aug, 2024 | Equity Share |
| 16 Feb, 2024 | 35 | INTERIM | 17 Feb, 2024 | Equity Share |
| 10 Aug, 2023 | 10 | FINAL | 10 Aug, 2023 | Equity Share |
| 17 Feb, 2023 | 25 | SPECIAL | 18 Feb, 2023 | Equity Share |
| 17 Feb, 2023 | 15 | INTERIM | 18 Feb, 2023 | Equity Share |
| 08 Aug, 2022 | 4 | FINAL | 10 Aug, 2022 | Equity Share |
| 10 Feb, 2022 | 30 | INTERIM | 12 Feb, 2022 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹720 | ₹975 | ₹1,604 | ₹2,053 | ₹1,745.10 | ₹1,081.95 |
| % Change | 4.24% | 0.15% | 2.47% | 0.54% | 0.96% | -0.05% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 83.50 | 62.20 | 35.00 | 47.70 | 34.00 | 69.40 |
| 1 Year Return | 26.36 | 43.56 | 70.22 | -12.49 | 22.7 | 87.09 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Biocon Ltd.
₹ 345.95
-1.10%
Divi's Laboratories Ltd.
₹ 5955.50
+1.25%
Ajanta Pharma Ltd.
₹ 2750.00
+1.51%
Zydus Lifesciences Ltd.
₹ 900.00
-
Glenmark Pharmaceuticals Ltd.
₹ 2161.80
-0.54%
Wockhardt Ltd.
₹ 1365.00
+1.13%
Aurobindo Pharma Ltd.
₹ 1339.20
+0.26%
Sun Pharmaceutical Industries Ltd.
₹ 1715.00
+0.02%
Ipca Laboratories Ltd.
₹ 1450.00
+0.35%
J B Chemicals & Pharmaceuticals Ltd.
₹ 1965.10
+1.16%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2357.00
+0.11%
Pfizer Ltd.
₹ 4735.00
-2.08%
Abbott India Ltd.
₹ 25765.00
-0.33%
Torrent Pharmaceuticals Ltd.
₹ 4090.00
+1.51%
Lupin Ltd.
₹ 2292.30
-0.08%
Dr. Reddy's Laboratories Ltd.
₹ 1211.00
+1.65%
Cipla Ltd.
₹ 1225.00
+0.75%
By signing up I certify terms, conditions & privacy policy